1Bone RC,Balk RA,Cerra FB,et al.Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis.The ACCP/SCCM Consensus Conference Committee.American College of Chest Physicians/ Society of Critical Care Medicine[J].Chest,1992; 101:1644-1655.
2Matot I,Sprung CL.Definition of sepsis[J].Intensive Care Med,2001,27:S3-S9.
3Opal SM,Esmon CT.Bench-to-bedside review: functional relationships between coagulation and the innate immune response and their respective roles in the pathogenesis of sepsis[J].Crit Care,2003,7:23-38.
4Landry DW,Oliver JA.The pathogenesis of vasodilatory shock[J].N Engl J Med,2001,345:588-595.
5Rivers E,Nguyen B,Havstad S,et al.Early goal-directed therapy in the treatment of severe sepsis and septic shock[J].N Engl J Med,2001,345:1368-1377.
6Dellinger RP,Carlet JM,Masur H,et al.Surviving sepsis campaign guidelines for management of severe sepsis and septic shock[J].Crit Care Med,2004,32:858-873.
7MacArthur RD,Miller M,Albertson T,et al.Adequacy of early empiric antibiotic treatment and survival in severe sepsis: experience from the MONARCS trial[J].Clin Infect Dis,2004,38:284-288.
8Leibovici L,Paul M,Poznanski O,et al.Monotherapy versus beta-lactam-aminoglycoside combination treatment for gram-negative bacteremia: a prospective,observational study[J].Antimicrob Agents Chemother,1997,41:1127.
9Balk RA.Severe sepsis and septic shock: definitions,epidemiology,and clinical manifestations[J].Crit Care Clin,2000,16:179-192.
10The Acute Respiratory Distress Syndrome Network.Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome[J].N Engl J Med,2000,342:1301-1308.
9Opal SM,Esmon CT.Bench-to-bedside review:functional relation ships between coagulation and the innate immune responseand their respective roles in the pathogenesis of sepsis[J].Crit Care,2003,7:23-38.
10Landry DW,Oliver JA.The pathogenesis of vasodilatory shock[J].N Engl J Med,2001,345:588-595.
